ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Morphine Gel for Bedsores

This study has been completed.

Sponsored by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
ClinicalTrials.gov Identifier: NCT00007254
  Purpose

This study tests the effectiveness of a morphine-containing gel for reducing pain caused by pressure ulcers, also known as bedsores or pressure sores. We will apply the gel containing morphine, or the gel alone, directly onto painful pressure ulcers and compare the results.


Condition Intervention Phase
Decubitus Ulcer
Drug: Pain relief for pressure ulcers
Phase I
Phase II

MedlinePlus related topics:   Pressure Sores   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title:   Morphine-Infused Gel for Pressure Ulcer Analgesia

Further study details as provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS):

Estimated Enrollment:   75
Study Start Date:   March 2000
Estimated Study Completion Date:   February 2003

Detailed Description:

In this study, we will apply a morphine-containing gel (or placebo) directly onto painful pressure ulcers. We will take participants off of any opioid-containing medications upon entry into the study. This allows us to measure any morphine that may enter into the bloodstream from the topically applied gel.

The purpose of this study is to examine the efficacy of the gel for pressure ulcer analgesia, as well as the systemic absorption of morphine from the topically applied gel. We will document the amount of pain medications taken by participants to determine whether the gel decreases the need for these drugs.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Presence of a Stage II pressure ulcer.
  • Pressure ulcer must be painful.
  • Primary Care physician must approve participation.
  • Thinking ability must be clear and intact.
  • Willing to change pain medication to oxycodone.

Exclusion Criteria:

  • Allergy to morphine, oxycodone or intrasite gel.
  • Use of codeine- or morphine-containing medications.
  • Use of pain medications for anything other than the pressure ulcer.
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00007254

Locations
United States, Kansas
The University of Kansas Medical Center    
      Kansas City, Kansas, United States, 66160
United States, Missouri
Kindred Hospital    
      Kansas City, Missouri, United States

Sponsors and Collaborators

Investigators
Principal Investigator:     Teresa D. Long, MD     The University of Kansas Medical Center    
  More Information


Publications:

Study ID Numbers:   R01 AR45506, NIAMS-061
First Received:   December 16, 2000
Last Updated:   January 2, 2007
ClinicalTrials.gov Identifier:   NCT00007254
Health Authority:   United States: Federal Government

Keywords provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS):
Analgesia  
Bedsore  
Morphine gel  
Pressure ulcer
Pain
Ulcer

Study placed in the following topic categories:
Morphine
Skin Diseases
Ulcer
Pain
Skin Ulcer
Pressure Ulcer

Additional relevant MeSH terms:
Pathologic Processes
Sensory System Agents
Therapeutic Uses
Physiological Effects of Drugs
Central Nervous System Depressants
Narcotics
Peripheral Nervous System Agents
Analgesics
Central Nervous System Agents
Pharmacologic Actions
Analgesics, Opioid

ClinicalTrials.gov processed this record on October 10, 2008




Links to all studies - primarily for crawlers